ヘルペス感染症(Herpes Infections):世界の治験レビュー(2014年下半期版)

◆英語タイトル:Herpes Infections Global Clinical Trials Review, H2, 2014
◆商品コード:GDHC2452CTIDB
◆発行会社(リサーチ会社):GlobalData
◆発行日:2014年11月30日
◆ページ数:128
◆レポート言語:英語
◆レポート形式:PDF
◆納品方法:Eメール
◆調査対象地域:グローバル
◆販売価格オプション(消費税別)
Single UserUSD2,500 ⇒換算¥260,000見積依頼/購入/質問フォーム
Site License(同一国内共有可)USD5,000 ⇒換算¥520,000見積依頼/購入/質問フォーム
Global Site License(複数国内共有可)USD7,500 ⇒換算¥780,000見積依頼/購入/質問フォーム
販売価格オプションの説明はこちらでご利用ガイドはこちらでご確認いただけます。
※お支払金額は「換算金額(日本円)+消費税+配送料(Eメール納品は無料)」です。
※本体価格が¥30,000未満のレポートにつきましては、ハンドリングチャージ¥5,000が別途かかります。
※Eメールによる納品の場合、通常ご注文当日~2日以内に納品致します。
※レポート納品後、納品日+5日以内に請求書を発行し、お客様宛に郵送しますので、請求書発行日より2ヶ月以内に振込をお願いします。
※上記の日本語題名はH&Iグローバルリサーチが翻訳したものです。英語版原本には日本語表記はありません。
※為替レートは適宜修正・更新しております。リアルタイム更新ではありません。
※弊社H&Iグローバルリサーチ株式会社はGlobalData社の日本における正規販売代理店です。同社発行の医療分野調査レポートに関するお問い合わせは弊社までお願い致します。
GlobalData社の概要はこちらでご確認いただけます。
※上記「見積依頼/購入/質問フォーム」をクリックすると弊社運営のレポート販売サイトに移動します。

当調査レポートでは、世界におけるヘルペス感染症(Herpes Infections) 治療の臨床試験動向について調査・分析し、アジア太平洋/欧州/北米/中南米の主要国における治験件数、段階(フェーズ)別の治験件数、進捗状況別の治験件数、治験目標の達成状況、有望な薬剤、治験関連の最新ニュース、代表的な企業・大学・研究機関における治験概要、代表的な治験のプロファイルなどのデータをまとめてお届けいたします。

・イントロダクション
  - ヘルペス感染症(Herpes Infections)
  - 当レポートの概要
・ヘルペス感染症(Herpes Infections):各地域別治験状況
  - 各国の治験件数及び平均被験者数
   アジア太平洋の主要国における治験件数
   欧州の主要国における治験件数
   北米の主要国における治験件数
   中東・アフリカの主要国における治験件数
   中南米の主要国における治験件数
・G7諸国での治験件数
・G7諸国での治験件数:段階別
・G7諸国での治験件数:進捗状況別
・段階(フェーズ)別の治験件数:進行中の治験(段階別)
・進捗状況別の治験件数
・治験目標の達成状況
・未完了の治験件数
・一定期間に採用された被験者
・スポンサーの種類別治験件数
・有望なスポンサー
・有望な薬剤
・治験のプロファイル
  - 代表的な企業における治験概要
  - 代表的な大学・研究機関における治験概要
・5つの代表的な治験のプロファイル
【レポートの概要】

Herpes Infections Global Clinical Trials Review, H2, 2014

Summary

GlobalData’s clinical trial report, “Herpes Infections Global Clinical Trials Review, H2, 2014″ provides data on the Herpes Infections clinical trial scenario. This report provides elemental information and data relating to the clinical trials on Herpes Infections. It includes an overview of the trial numbers and their recruitment status as per the site of trial conduction across the globe. The databook offers a preliminary coverage of disease clinical trials by their phase, trial status, prominence of the sponsors and also provides briefing pertaining to the number of trials for the key drugs for treating Herpes Infections. This report is built using data and information sourced from proprietary databases, primary and secondary research and in-house analysis by GlobalData’s team of industry experts.

Note: Certain sections in the report may be removed or altered based on the availability and relevance of data for the indicated disease.

Scope

- Data on the number of clinical trials conducted in North America, South and Central America, Europe, Middle-East and Africa and Asia-pacific and top five national contributions in each
- Clinical trial (complete and in progress) data by phase, trial status, subjects recruited and sponsor type
- Listings of discontinued trials (suspended, withdrawn and terminated)

Reasons to buy

- Understand the dynamics of a particular indication in a condensed manner
- Abridged view of the performance of the trials in terms of their status, recruitment, location, sponsor type and many more
- Obtain discontinued trial listing for trials across the globe
- Espy the commercial landscape of the major Universities / Institutes / Hospitals or Companies

【レポートの目次】

Table of Contents
Table of Contents 2
List of Tables 4
List of Figures 5
Introduction 6
Herpes Infections 6
Report Guidance 6
Clinical Trials by Region 7
Clinical Trials and Average Enrollment by Country 8
Top Five Countries Contributing to Clinical Trials in Asia-Pacific 10
Top Five Countries Contributing to Clinical Trials in Europe 11
Top Countries Contributing to Clinical Trials in North America 12
Top Five Countries Contributing to Clinical Trials in Middle East and Africa 13
Top Five Countries Contributing to Clinical Trials in Central and South America 14
Clinical Trials by G7 Countries: Proportion of Herpes Infections to Infectious Disease Clinical Trials 15
Clinical Trials by Phase in G7 Countries 16
Clinical Trials in G7 Countries by Trial Status 17
Clinical Trials by E7 Countries: Proportion of Herpes Infections to Infectious Disease Clinical Trials 18
Clinical Trials by Phase in E7 Countries 19
Clinical Trials in E7 Countries by Trial Status 20
Clinical Trials by Phase 21
In Progress Trials by Phase 22
Clinical Trials by Trial Status 23
Clinical Trials by End Point Status 24
Unaccomplished Trials of Herpes Infections 25
Subjects Recruited Over a Period of Time 31
Clinical Trials by Sponsor Type 32
Prominent Sponsors 33
Top Companies Participating in Herpes Infections Therapeutics Clinical Trials 34
Prominent Drugs 35
Latest Clinical Trials News on Herpes Infections 36
Oct 08, 2014: NanoBio To Present Data Demonstrating The Potential For Its Intranasal Vaccine To Protect Against Genital Herpes Infection 36
Clinical Trial Profiles 37
Clinical Trial Overview of Top Companies 37
GlaxoSmithKline plc 37
Clinical Trial Overview of GlaxoSmithKline plc 37
Merck & Co., Inc. 44
Clinical Trial Overview of Merck & Co., Inc. 44
F. Hoffmann-La Roche Ltd. 48
Clinical Trial Overview of F. Hoffmann-La Roche Ltd. 48
Novartis AG 52
Clinical Trial Overview of Novartis AG 52
Astellas Pharma Inc. 54
Clinical Trial Overview of Astellas Pharma Inc. 54
Sanofi 55
Clinical Trial Overview of Sanofi 55
Pfizer Inc. 56
Clinical Trial Overview of Pfizer Inc. 56
AstraZeneca PLC 57
Clinical Trial Overview of AstraZeneca PLC 57
Vical Incorporated 59
Clinical Trial Overview of Vical Incorporated 59
Gilead Sciences, Inc. 60
Clinical Trial Overview of Gilead Sciences, Inc. 60
Clinical Trial Overview of Top Institutes / Government 61
The National Institute of Allergy and Infectious Diseases 61
Clinical Trial Overview of The National Institute of Allergy and Infectious Diseases 61
National Cancer Institute 66
Clinical Trial Overview of National Cancer Institute 66
University of Washington 68
Clinical Trial Overview of University of Washington 68
National Heart, Lung, and Blood Institute 69
Clinical Trial Overview of National Heart, Lung, and Blood Institute 69
National Center for Research Resources 70
Clinical Trial Overview of National Center for Research Resources 70
National Eye Institute 71
Clinical Trial Overview of National Eye Institute 71
Baylor College of Medicine 72
Clinical Trial Overview of Baylor College of Medicine 72
University of California, San Francisco 73
Clinical Trial Overview of University of California, San Francisco 73
University of Alabama at Birmingham 74
Clinical Trial Overview of University of Alabama at Birmingham 74
Memorial Sloan Kettering Cancer Center 75
Clinical Trial Overview of Memorial Sloan Kettering Cancer Center 75
Five Key Clinical Profiles 76
Appendix 126
Abbreviations 126
Definitions 126
Research Methodology 127
Secondary Research 127
About GlobalData 128
Contact Us 128
Disclaimer 128
Source 128

List of Tables
Herpes Infections Therapeutics, Global, Clinical Trials by Region, 2014* 7
Herpes Infections Therapeutics, Global, Clinical Trials and Average Enrollment by Top Countries, 2014* 8
Herpes Infections Therapeutics, Global, Clinical Trials In Progress by Top Countries, 2014* 9
Herpes Infections Therapeutics Clinical Trials, Asia-Pacific, Top Five Countries, 2014* 10
Herpes Infections Therapeutics Clinical Trials, Europe, Top Five Countries, 2014* 11
Herpes Infections Therapeutics Clinical Trials, North America, Top Countries, 2014* 12
Herpes Infections Therapeutics Clinical Trials, Middle East and Africa, Top Five Countries, 2014* 13
Herpes Infections Therapeutics Clinical Trials, Central and South America, Top Five Countries, 2014* 14
Proportion of Herpes Infections to Infectious Disease Clinical Trials, G7 Countries (%), 2014* 15
Herpes Infections Therapeutics, G7 Countries, Clinical Trials by Phase, 2014* 16
Herpes Infections Therapeutics, G7 Countries, Clinical Trials by Trial Status, 2014* 17
Proportion of Herpes Infections to Infectious Disease Clinical Trials, E7 Countries (%), 2014* 18
Herpes Infections Therapeutics, E7 Countries, Clinical Trials by Phase, 2014* 19
Herpes Infections Therapeutics, E7 Countries, Clinical Trials by Trial Status, 2014* 20
Herpes Infections Therapeutics, Global, Clinical Trials by Phase, 2014* 21
Herpes Infections Therapeutics, Global, Clinical Trials In Progress by Phase 2014* 22
Herpes Infections Therapeutics, Global, Clinical Trials by Trial Status, 2014* 23
Herpes Infections Therapeutics Clinical Trials, Global, by End Point Status, 2014* 24
Herpes Infections Therapeutics, Global, Suspended Clinical Trials, 2014* 25
Herpes Infections Therapeutics, Global, Withdrawn Clinical Trials, 2014* 26
Herpes Infections Therapeutics, Global, Terminated Clinical Trials, 2014* 28
Herpes Infections Therapeutics Clinical Trials, Global, Average Enrollment Target Trends, 2009-2013 31
Herpes Infections Therapeutics Market, Global, Clinical Trials by Sponsor Type, 2014* 32
Herpes Infections Therapeutics Clinical Trials, Global, Key Sponsors, 2014* 33
Herpes Infections Therapeutics Clinical Trials, Global, Top Companies by Phase, 2014* 34
Herpes Infections Therapeutics Clinical Trials, Global, Ongoing Clinical Trials by Prominent Drugs, 2014* 35
Herpes Infections Therapeutics Clinical Trials Market, Global, Clinical Trials by GlaxoSmithKline plc, 2014* 37
Herpes Infections Therapeutics Clinical Trials Market, Global, Clinical Trials by Merck & Co., Inc., 2014* 44
Herpes Infections Therapeutics Clinical Trials Market, Global, Clinical Trials by F. Hoffmann-La Roche Ltd., 2014* 48
Herpes Infections Therapeutics Clinical Trials Market, Global, Clinical Trials by Novartis AG, 2014* 52
Herpes Infections Therapeutics Clinical Trials Market, Global, Clinical Trials by Astellas Pharma Inc., 2014* 54
Herpes Infections Therapeutics Clinical Trials Market, Global, Clinical Trials by Sanofi, 2014* 55
Herpes Infections Therapeutics Clinical Trials Market, Global, Clinical Trials by Pfizer Inc., 2014* 56
Herpes Infections Therapeutics Clinical Trials Market, Global, Clinical Trials by AstraZeneca PLC, 2014* 57
Herpes Infections Therapeutics Clinical Trials Market, Global, Clinical Trials by Vical Incorporated, 2014* 59
Herpes Infections Therapeutics Clinical Trials Market, Global, Clinical Trials by Gilead Sciences, Inc., 2014* 60
Herpes Infections Therapeutics Clinical Trials Market, Global, Clinical Trials by The National Institute of Allergy and Infectious Diseases, 2014* 61
Herpes Infections Therapeutics Clinical Trials Market, Global, Clinical Trials by National Cancer Institute, 2014* 66
Herpes Infections Therapeutics Clinical Trials Market, Global, Clinical Trials by University of Washington, 2014* 68
Herpes Infections Therapeutics Clinical Trials Market, Global, Clinical Trials by National Heart, Lung, and Blood Institute, 2014* 69
Herpes Infections Therapeutics Clinical Trials Market, Global, Clinical Trials by National Center for Research Resources, 2014* 70
Herpes Infections Therapeutics Clinical Trials Market, Global, Clinical Trials by National Eye Institute, 2014* 71
Herpes Infections Therapeutics Clinical Trials Market, Global, Clinical Trials by Baylor College of Medicine, 2014* 72
Herpes Infections Therapeutics Clinical Trials Market, Global, Clinical Trials by University of California, San Francisco, 2014* 73
Herpes Infections Therapeutics Clinical Trials Market, Global, Clinical Trials by University of Alabama at Birmingham, 2014* 74
Herpes Infections Therapeutics Clinical Trials Market, Global, Clinical Trials by Memorial Sloan Kettering Cancer Center, 2014* 75

List of Figures
Herpes Infections Therapeutics, Global, Clinical Trials by Region (%), 2014* 7
Herpes Infections Therapeutics, Global, Clinical Trials and Average Enrollment by Top Countries, 2014* 8
Herpes Infections Therapeutics, Global, Clinical Trials In Progress by Top Countries, 2014* 9
Herpes Infections Therapeutics Clinical Trials, Asia-Pacific, Top Five Countries (%), 2014* 10
Herpes Infections Therapeutics Clinical Trials, Europe, Top Five Countries (%), 2014* 11
Herpes Infections Therapeutics Clinical Trials, North America, Top Countries (%), 2014* 12
Herpes Infections Therapeutics Clinical Trials, Middle East and Africa, Top Five Countries (%), 2014* 13
Herpes Infections Therapeutics Clinical Trials, Central and South America, Top Five Countries (%), 2014* 14
Proportion of Herpes Infections to Infectious Disease Clinical Trials, G7 Countries (%), 2014* 15
Herpes Infections Therapeutics, G7 Countries, Clinical Trials by Phase, 2014* 16
Herpes Infections Therapeutics, G7 Countries, Clinical Trials by Trial Status, 2014* 17
Proportion of Herpes Infections to Infectious Disease Clinical Trials, E7 Countries (%), 2014* 18
Herpes Infections Therapeutics, E7 Countries, Clinical Trials by Phase, 2014* 19
Herpes Infections Therapeutics, E7 Countries, Clinical Trials by Trial Status, 2014* 20
Herpes Infections Therapeutics, Global, Clinical Trials by Phase (%), 2014* 21
Herpes Infections Therapeutics, Global, Clinical Trials In Progress by Phase, 2014* 22
Herpes Infections Therapeutics, Global, Clinical Trials by Trial Status, 2014* 23
Herpes Infections Therapeutics Clinical Trials, Global, by End Point Status, 2014* 24
Herpes Infections Therapeutics Clinical Trials, Global, Average Enrollment Target Trends, 2009-2013 31
Herpes Infections Therapeutics Market, Global, Clinical Trials by Sponsor Type (%), 2014* 32
Herpes Infections Therapeutics Clinical Trials, Global, Key Sponsors, 2014* 33
Herpes Infections Therapeutics Clinical Trials, Global, Top Companies by Phase, 2014* 34
Herpes Infections Therapeutics Clinical Trials, Global, Ongoing Clinical Trials by Prominent Drugs, 2014* 35
GlobalData Methodology 127

【免責事項】
https://www.marketreport.jp/reports-disclaimer

★医療情報レポート[ヘルペス感染症(Herpes Infections):世界の治験レビュー(2014年下半期版)]についてメールでお問い合わせはこちら



◆H&Iグローバルリサーチ株式会社のお客様(例)◆